Company Sienna Biopharmaceuticals, Inc.
Equities
SNNAQ
US82622H1086
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
Business Summary
Number of employees: 13
Managers
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 10-06-26 | |
Majed Kheir
COO | Chief Operating Officer | 46 | 15-12-31 |
Silvio Traversa
CTO | Chief Tech/Sci/R&D Officer | 54 | 16-11-30 |
Sean P. Andrews
IRC | Investor Relations Contact | - | - |
General Counsel | 45 | 16-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dennis Fenton
BRD | Director/Board Member | 72 | 16-09-30 |
Founder | 59 | 10-06-26 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 31,050,542 | 30,907,542 ( 99.54 %) | 143,000 ( 0.4605 %) | 99.54 % |
Company contact information
Sienna Biopharmaceuticals, Inc.
30699 Russell Ranch Road Suite 140
91362, Westlake Village
+
Sector
1st Jan change | Capi. | |
---|---|---|
0.00% | 22 | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.57% | 22.1B | |
-9.16% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- SNNAQ Stock
- Company Sienna Biopharmaceuticals, Inc.